Medications

FDA: Omontys injection pulled from market

(HealthDay)—Affymax Inc. of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited of Deerfield, Ill., have voluntarily recalled all lots of Omontys Injection, used to treat anemia in adult dialysis patients, following ...

Diseases, Conditions, Syndromes

Peginesatide safe for anemia in patients undergoing dialysis

(HealthDay)—Peginesatide, a peptide-based erythropoiesis-stimulating agent, is safe and effective in patients with advanced chronic kidney disease and anemia as long as they are undergoing dialysis, according to two studies ...

Diseases, Conditions, Syndromes

Malaria drug association with hemolytic anemia unclear

(HealthDay)—Artesunate, a drug used in the treatment of severe malaria, may or may not be associated with hemolytic anemia, so the U.S. Centers for Disease Control and Prevention recommends close monitoring of patients ...

Pediatrics

Keep tots' milk to two cups a day, study says

(HealthDay)—Drinking two cups of milk a day gives toddlers adequate amounts of vitamin D without lowering their iron levels, according to new research.

Oncology & Cancer

Synribo approved to treat rare leukemia

(HealthDay)—Synribo (omacetaxine mepesuccinate) has been approved by the U.S. Food and Drug Administration to treat a rare blood and bone marrow disease called chronic myelogenous leukemia (CML).

Oncology & Cancer

Abraxane approved to treat advanced lung cancer

(HealthDay)—Abraxane (paclitaxel protein-bound) has been approved by the U.S. Food and Drug Administration—in combination with the drug carboplatin—to treat advanced or spreading non-small cell lung cancer among people ...

Surgery

Severe anemia linked to poorer heart surgery outcomes

(HealthDay)—Adults undergoing cardiac surgery who have moderate-to-severe preoperative anemia have significantly increased morbidity and mortality compared with non-severely anemic patients, according to research published ...

page 24 from 28